Correlation Between Phio Pharmaceuticals and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Abcellera Biologics, you can compare the effects of market volatilities on Phio Pharmaceuticals and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Abcellera Biologics.
Diversification Opportunities for Phio Pharmaceuticals and Abcellera Biologics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Phio and Abcellera is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Abcellera Biologics
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Abcellera Biologics. In addition to that, Phio Pharmaceuticals is 1.21 times more volatile than Abcellera Biologics. It trades about -0.08 of its total potential returns per unit of risk. Abcellera Biologics is currently generating about 0.0 per unit of volatility. If you would invest 278.00 in Abcellera Biologics on August 24, 2024 and sell it today you would lose (6.00) from holding Abcellera Biologics or give up 2.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Abcellera Biologics
Performance |
| Timeline |
| Phio Pharmaceuticals Corp |
| Abcellera Biologics |
Phio Pharmaceuticals and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phio Pharmaceuticals and Abcellera Biologics
The main advantage of trading using opposite Phio Pharmaceuticals and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |